Navigation Links
Haemonetics Announces Change to Board of Directors
Date:4/6/2009

BRAINTREE, Mass., April 6 /PRNewswire-FirstCall/ -- Haemonetics Corporation (NYSE: HAE) announced today that Richard Meelia has retired from its Board of Directors effective April 2, 2009. Mr. Meelia is Chairman, President and CEO of Covidien Ltd., a global healthcare products company. He is retiring from Haemonetics' Board in order to spend more professional time on Covidien's operations.

Brad Nutter, Chairman of Haemonetics' Board of Directors, said, "We appreciate Rich's leadership and guidance during his four-year tenure with Haemonetics. His breadth of experience in healthcare has been a strong complement to the Board, particularly as we've made key strategic decisions and transformed the Company from a niche medical device company to the global leader in blood management solutions for our customers."

Mr. Meelia said, "During the past four years, Haemonetics made remarkable progress in transitioning into a higher growth profile company and is well positioned to deliver on its strategic and operational goals. I am proud of my association with the Company, its employees and my colleagues on the Board. There is an exciting future in store for this business."

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing innovative blood management solutions for our customers. Together, our devices and consumables, IT products, and consulting services deliver a suite of business solutions to help our customers improve clinical outcomes and reduce the cost of healthcare for blood collectors, hospitals, and patients around the world. Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit our web site at http://www.haemonetics.com.

    Contact:
    Julie Fallon
    Tel. (781) 356-9517
    Alt. Tel. (617) 320-2401


'/>"/>
SOURCE Haemonetics Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Haemonetics Bolsters Blood Bank Information Management Portfolio With Acquisition of Altivation Software
2. Haemonetics Reports Double Digit Growth in Revenue, Operating Income, and EPS for the Third Quarter Fiscal 2009
3. Haemonetics to Present at J.P. Morgan Healthcare Conference
4. Dr. Jonathan White Joins Haemonetics as Head of Research and Development
5. Haemonetics Announces Promotion of Brian Concannon to CEO Effective April 2009
6. Haemonetics Sets Date for First Quarter Fiscal Year 2009 Earnings Release and Conference Call - August 1, 2008
7. Haemonetics Chairman and CEO Adopts 10b5-1 Stock Trading Plan
8. Haemonetics Reports Strong Results for Fourth Quarter and Fiscal Year End 2008 and Issues Guidance for Continued Strong Growth in Fiscal 2009
9. Haemonetics Sets Date for Fourth Quarter and Fiscal Year End 2008 Earnings Release and Conference Call - May 1, 2008
10. Haemonetics(R) Software Solutions to Launch Application for Workflow Optimization in Blood Collection Centers
11. Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... Linda, CA (PRWEB) , ... ... ... an approach to healthcare that considers individuals’ genetic characteristics and the physical ... and precision therapy work in sync. In personalized medicine, diagnosing an individual’s ...
(Date:5/31/2016)... ... May 31, 2016 , ... St. Joseph Medical ... health information exchange, which enables physicians at SJMC’s two hospital campuses, downtown and ... participating organizations in the exchange. SJMC’s membership in the health information exchange underscores ...
(Date:5/31/2016)... ... May 31, 2016 , ... ... back to particular advertising campaigns, to monitor the performance of sales and support ... maximize conversions and revenue. The software allows customers to record, transcribe, route, document, ...
(Date:5/31/2016)... ... May 31, 2016 , ... The Global Wellness Summit (GWS), ... on the future of wellness, travel, spa and beauty in Europe. The organization asked ... companies to leading economists and researchers - to forecast where wellness is headed in ...
(Date:5/31/2016)... ... ... Interest is on the rise for using the CRISPR-Cas9 system for functional ... hit validation. A key reason may be that high-throughput synthesis—combined with a proprietary algorithm ... collections in arrayed formats. , Arrayed crRNA screens have the advantage ...
Breaking Medicine News(10 mins):
(Date:5/31/2016)... Israel , May 31, 2016 CollPlant ... proprietary plant-based rhCollagen technology for tissue repair products - ... Scientist of Israel,s Ministry of ... million development project for 2016. The Chief Scientist,s grant amount ... authorized grant, which totaled NIS 4.7 million.  ...
(Date:5/31/2016)... PUNE, India , May 31, 2016 ... 2016" market research report with comparative analysis of Asthma ... mechanism of action (MoA), route of administration (RoA) and ... and press releases. It also reviews key players involved ... on late-stage and discontinued projects. Complete report ...
(Date:5/30/2016)... 30, 2016 According to ... Services Market by Type (Stability, Raw Materials, Method ... User (Pharmaceutical Companies, Medical Device Companies) - Global ... witnessed healthy growth during the last decade and ... 11.3% between 2016 and 2021 to reach USD ...
Breaking Medicine Technology: